
Pipzo 1.125 gm Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Piperacillin (1000mg) + Tazobactum (125mg)
Overview Pipzo 1.125 gm Injection
Cefoperazone and Sulbactam 1.125g injection combats bacterial infections by eliminating microorganisms. This dual-antibiotic formulation requires administration by a medical professional; self-injection is strongly discouraged. Dosage and frequency are determined by your physician, based on the infection's severity, and must be strictly followed. Common side effects may encompass nausea, vomiting, diarrhea, skin rashes, and injection site reactions such as pain, swelling, or redness. Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions to your doctor; adjustments to dosage or alternative medications may be necessary. While generally safe during pregnancy and lactation under medical supervision, consultation with your doctor is essential.
Uses of Pipzo 1.125 gm Injection
Infections caused by bacteria
Major Benefits of Pipzo 1.125 gm Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Pipzo 1.125 gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Pipzo 1.125 gm Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Pipzo 1.125 gm Injection works:
Pipzo 1.125 gm Injection combines Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counters bacterial resistance, thereby boosting Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Pipzo 1.125 gm Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Pipzo (1.125 gm) is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or absent negative consequences for the fetus; nevertheless, clinical data in pregnant women remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Pipzo Injection (1.125 gm) is considered safe while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pipzo 1.125 gm Injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, administering Pipzo 1.125 gm Injection requires careful consideration. A modified dosage of Pipzo 1.125 gm Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Pipzo 1.125 gm Injection in patients with liver impairment appears to pose minimal risk. Preliminary findings indicate that dose modification may not be necessary for this patient group. However, physician consultation is recommended.
What if you forget to take Pipzo 1.125 gm Injection :
Omit a Pipzo 1.125 gm Injection dose? Seek your physician's advice.
Facts to Know About Pipzo 1.125 gm Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Agents against infection |
